A year-and-a-half after the In-Custody Death Review Division was created within a state agency, the office has yet to obtain ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
SK Hynix’s clever 5-bit flash could revolutionize SSD density while keeping costs stubbornly high for users ...
The mini review brings together emerging evidence showing that glial cells actively influence disease progression and ...
Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...
This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.
T cells are central mediators of autoimmune disease pathogenesis, yet their functional states are not defined solely by antigen recognition or canonical ...
The Trump administration announced Thursday that human fetal tissue derived from abortions can no longer be used in research ...
“HHS is ending the use of human fetal tissue from elective abortions in agency-funded research and replacing it with ...
From supplements to scalp serums, here’s how the popular gray-hair brand performed IRL.
NORTH HAVEN, Conn. (WTNH) — A large crowd gathered at a public information meeting Tuesday evening in North Haven as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results